An optical coherence tomography study to determine stent coverage in polymer coated versus bare metal rapamycin [sirolimus] eluting stents.

Trial Profile

An optical coherence tomography study to determine stent coverage in polymer coated versus bare metal rapamycin [sirolimus] eluting stents.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2010

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial infarction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Oct 2009 United Kingdom Clinical Research Network reports accrual to date changed from 82% to 87%.
    • 13 Oct 2009 Planned end date changed from 1 Aug 2007 to 1 Aug 2009 as reported by United Kingdom Clinical Research Network.
    • 13 Oct 2009 New source identified and integrated (United Kingdom Clinical Research Network record no. 4130).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top